JULIYA ROITMAN: Open Payments
NPI 1174001549 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,109 in 82 payments from 22 companies in 2025. Trend: 2023 $1,598 · 2024 $1,980 · 2025 $4,109
Travel & lodging: $2,085Food & beverage: $2,023
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 18 | $2,442 |
| Corcept Therapeutics | 6 | $229 |
| Lilly USA, LLC | 9 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $163 |
| Novo Nordisk Inc | 7 | $149 |
| Abbott Laboratories | 3 | $148 |
| Amgen Inc. | 5 | $102 |
| Antares Pharma, Inc. | 3 | $94 |
| Dexcom, Inc. | 3 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
Products named: JARDIANCE, Korlym, FREESTYLE LIBRE 3, EVENITY, XYOSTED, Dexcom G6 Transmitter, RECORLEV, AFREZZA.
Industry payments across NY — which companies pay providers there.
